Photo taken from Pashtoon Murtaza Kasi/Twitter.
Sep 24, 2023, 18:03
Pashtoon Murtaza Kasi: The imagery at RareCyte Incorporated will blow your mind.
Quoting Pashtoon Murtaza Kasi, Oncologist and Researcher at Weill Cornel Medicine and New York- Presbyterian Hospital, on X/Twitter:
“The imagery at RareCyte Incorporated will blow your mind. Here’s just a simple depiction of PD-L1 around the tumor. You can see the dramatic increase pre- and post-treatment with the BOT (botensilimab) immunotherapy. We used the 13-plex Immuno-oncology.”
For more information click here.
Source: Pashtoon Murtaza Kasi/Twitter.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12